戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ions on male reproductive health and perhaps birth control.
2 h control, but 23% (1013/4294) wanted to use birth control.
3 d the use of this highly effective method of birth control.
4 s how the anti-progestin RU486 might work in birth control.
5  daycare attendance, and the use of hormonal birth control.
6 imane', Yali, and Bhotiya-who employ natural birth control.
7 cluded and 1449 women were available as live birth controls.
8 quent nonuse reasons were not wanting to use birth control (27.1%) and side effect concerns (25.0%).
9 ome devices, such as an implanted device for birth control and a surgical mesh implant for pelvic org
10 ing at a more balanced age structure through birth control and family planning.
11 tal infection and infection of partner(s)', 'Birth control and pregnancy management'.
12 e of, and confidence in prescribing hormonal birth control and reports of pharmacy-level practices.
13 ng on the pollutant, a maximum of 4,632 live-birth controls and 3,328 live-birth, fetal-death, or ele
14 acy that provided prescriptions for hormonal birth control, and 149 who did not reported barriers suc
15  of women using data from the Natural Cycles birth control application in each Sweden and the United
16 national English-speaking users of a digital birth control application.
17 der to determine the most appropriate animal birth control approach.
18  indicated that providing access to hormonal birth control as a prescribing provider was important (2
19 estions, such as those concerning the use of birth control, as measured by the kappa statistic, was m
20 lence, condom use, and use of other forms of birth control at last penile-vaginal or penile-anal sex)
21                Of 4881 women, 597 (12%) used birth control, but 23% (1013/4294) wanted to use birth c
22 nt areas such as vascular disease treatment, birth control, cancer treatment, and eye disease treatme
23                 Use of the progesterone (Pg) birth control depot medroxyprogesterone acetate (DMPA) i
24 re services, including Papanicolaou tests or birth control, experienced in the past 3 years.
25 re study population and separately by sex at birth, controlling for additional covariates.
26 l depressive symptoms to spontaneous preterm birth, controlling for behavioral, clinical, and demogra
27 e or clean delivery practices in 19,754 home births, controlling for confounders common to all study
28 y (0 to 7 days) neonatal mortality per 1,000 births, controlling for potential confounders including
29 ibility of using immunization as a method of birth control has been explored actively since the 1930s
30                             Various forms of birth control have been developed for women; however, th
31 pausal status in relation to use of hormonal birth control (HBC) and hormone replacement therapy (HRT
32 ytokine profiles from 45 preterm and 90 term birth controls identified harbingers of preterm birth in
33  incidence analysis, we registered a year-of-birth controlled incidence analysis of 4.04 per 100.000
34 sts held favorable attitudes toward hormonal birth control, less than half (144 of 308 [46.8%]) worke
35  considered to predict the effects of animal birth control measures.
36 became pregnant by accident before efficient birth control methods were available and therefore were
37 , years of education mother's height, use of birth control, number of pregnancies, smoking before pre
38 BC risk for women who had ever used hormonal birth control (odds ratio [OR] = 2.20 versus 3.89) and a
39 rganizations as effective and well tolerated birth control options in this population.
40 he menstrual cycle, when using hormone-based birth control, or during pregnancy.
41                                       Use of birth control other than condoms at last sex was lower f
42 lake additions of an active component of the birth control pill (17alpha-ethynylestradiol; EE2) that
43 mand contraception, where a man would take a birth control pill shortly before sex, only as needed.
44 ory and hormone replacement therapy (HRT) or birth control pills (BCPs) influence risk for age-relate
45 ies and female-associated factors (intake of birth control pills or estrogens and number of births) w
46 amily members may need testing before taking birth control pills or hormonal replacement.
47 s a semisynthetic estrogen compound found in birth control pills, and its chemical structure allows t
48  assessed by 1 item-respondents could select birth control pills; condoms; an intrauterine device or
49          Pharmacy-level barriers to hormonal birth control prescription, such as insurance coverage f
50 ifornia pharmacists could prescribe hormonal birth control, providing an opportunity to learn about t
51 on for failed contraception, and prescribing birth control to adolescents without parental approval.
52 nclusion, the PRS may interact with hormonal birth control use and with menopausal status on risk of
53  selectively terminated cases and 3,972 live-birth controls were enrolled.
54 low parental educational levels and being on birth control when one got pregnant were associated with
55                         A desire to "discuss birth control with a health care provider at the lupus c
56 d pregnancy and are interested in discussing birth control with a health care provider.